Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Amortization of Deferred Charges (2020 - 2023)

Stevanato Group S.p.A (STVN) posted quarterly Amortization of Deferred Charges of $4.2 million for Q2 2023, up 8.71% year-over-year from $3.8 million in Q2 2022, and little changed quarter-over-quarter from $4.2 million in Q1 2023.

Stevanato Group S.p.A (STVN) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Amortization of Deferred Charges for 4 consecutive years, with $4.2 million the latest figure, recorded in Q2 2023.

  • In Q2 2023, Amortization of Deferred Charges rose 8.71% year-over-year to $4.2 million; the TTM figure through Jun 2023 stood at $15.9 million (up 0.66% YoY), while the FY2021 annual figure was $16.2 million, up 6.78% from the prior year.
  • Amortization of Deferred Charges was little changed at $4.2 million in Q2 2023 per STVN's latest filing, from $4.2 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $4.3 million in Q4 2020 and bottomed at $3.5 million in Q3 2020.
  • Historically, Amortization of Deferred Charges has averaged $4.0 million across 4 years, with a median of $4.1 million in 2021.
  • Annual changes were most pronounced in 2021 — Amortization of Deferred Charges increased 15.69% — and 2022, when it declined 10.5%.
  • Stevanato Group S.p.A's Amortization of Deferred Charges stood at $4.3 million in 2020, then decreased by 9.66% to $3.9 million in 2021, then dropped by 6.36% to $3.7 million in 2022, then gained by 13.75% to $4.2 million in 2023.
  • Business Quant data shows STVN's Amortization of Deferred Charges at $4.2 million in Q2 2023, $4.2 million in Q1 2023, and $3.7 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 4.18 Mn
Jun 30, 2023 4.18 Mn
Mar 31, 2023 4.18 Mn
Mar 31, 2023 4.18 Mn
Sep 30, 2022 3.67 Mn
Sep 30, 2022 3.67 Mn
Jun 30, 2022 3.84 Mn
Jun 30, 2022 3.84 Mn
Mar 31, 2022 3.90 Mn
Mar 31, 2022 3.90 Mn
Dec 31, 2021 3.92 Mn
Dec 31, 2021 3.92 Mn
Sep 30, 2021 4.10 Mn
Sep 30, 2021 4.10 Mn
Jun 30, 2021 4.13 Mn
Jun 30, 2021 4.13 Mn
Mar 31, 2021 4.06 Mn
Mar 31, 2021 4.06 Mn
Dec 31, 2020 4.34 Mn
Dec 31, 2020 4.34 Mn